Three insights:
1. Agilon is now cleared for use in posterolateral spine procedures when mixed with autograft.
2. The product features a high purity, type 1 fibrillar bovine collagen, which offers a site for cell attachment, migration, proliferation and differentiation.
3. The Irvine, Calif.-based company is accelerating national distribution of Agilon, which is available in three different sizes.
More articles on devices:
Rothman Orthopaedics surgeon to lead orthopedic oncology program
New Southeastern Spine Institute moves closer to completion
Kevin Lobo’s 8+ years as Stryker CEO: Leading 20+ acquisitions, boosting robotics & more
